1. Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment.
- Author
-
Hallengren E, Almgren P, Rosvall M, Östling G, Persson M, Bergmann A, Struck J, Engström G, Hedblad B, and Melander O
- Subjects
- Adrenergic beta-1 Receptor Antagonists therapeutic use, Aged, Aged, 80 and over, Biomarkers blood, Carotid Artery Diseases blood, Carotid Artery Diseases diagnostic imaging, Carotid Artery Diseases epidemiology, Cross-Sectional Studies, Double-Blind Method, Drug Therapy, Combination, Female, Fluvastatin, Humans, Linear Models, Male, Metoprolol therapeutic use, Middle Aged, Multivariate Analysis, Predictive Value of Tests, Randomized Controlled Trials as Topic, Risk Factors, Sex Factors, Sweden epidemiology, Time Factors, Treatment Outcome, Carotid Artery Diseases drug therapy, Carotid Intima-Media Thickness, Fasting blood, Fatty Acids, Monounsaturated therapeutic use, Human Growth Hormone blood, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Indoles therapeutic use
- Abstract
Background: Growth hormone (GH) has been linked to cardiovascular disease but the exact mechanism of this association is still unclear. We here test if the fasting levels of GH are cross-sectionally associated with carotid intima media thickness (IMT) and whether treatment with fluvastatin affects the fasting level of GH., Methods: We examined the association between GH and IMT in 4425 individuals (aged 46-68 years) included in the baseline examination (1991-1994) of the Malmö Diet and Cancer cardiovascular cohort (MDC-CC). From that cohort we then studied 472 individuals (aged 50-70 years) who also participated (1994-1999) in the β-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS), a randomized, double blind, placebo-controlled, single-center clinical trial. Using multivariate linear regression models we related the change in GH-levels at 12 months compared with baseline to treatment with 40 mg fluvastatin once daily., Results: In MDC-CC fasting values of GH exhibited a positive cross-sectional relation to the IMT at the carotid bulb independent of traditional cardiovascular risk factors (p = 0.002). In a gender-stratified analysis the correlation were significant for males (p = 0.005), but not for females (p = 0.09). Treatment with fluvastatin was associated with a minor reduction in the fasting levels of hs-GH in males (p = 0.05) and a minor rise in the same levels among females (p = 0.05)., Conclusions: We here demonstrate that higher fasting levels of GH are associated with thicker IMT in the carotid bulb in males. Treatment with fluvastatin for 12 months only had a minor, and probably not clinically relevant, effect on the fasting levels of hs-GH.
- Published
- 2017
- Full Text
- View/download PDF